These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25805398)

  • 1. Uterine carcinosarcoma: A review of the literature.
    Cantrell LA; Blank SV; Duska LR
    Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
    Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic and molecular features of uterine carcinosarcomas.
    Lopez-Garcia MA; Palacios J
    Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine carcinosarcomas: From pathology to practice.
    Toboni MD; Crane EK; Brown J; Shushkevich A; Chiang S; Slomovitz BM; Levine DA; Dowdy SC; Klopp A; Powell MA; Thaker PH
    Gynecol Oncol; 2021 Jul; 162(1):235-241. PubMed ID: 34030871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare uterine cancer: carcinosarcomas. Review from histology to treatment.
    Artioli G; Wabersich J; Ludwig K; Gardiman MP; Borgato L; Garbin F
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):98-104. PubMed ID: 25468677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcomas and mixed mesodermal tumors of the uterus].
    Günthert AR
    Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma.
    Elshaikh MA; Modh A; Jhingran A; Biagioli MC; Coleman RL; Gaffney DK; Harkenrider MM; Heskett K; Jolly S; Kidd E; Lee LJ; Li L; Portelance L; Sherertz T; Venkatessan AM; Wahl AO; Yashar CM; Small W
    Gynecol Oncol; 2020 Aug; 158(2):460-466. PubMed ID: 32475772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular classification and subtype-specific drug sensitivity research of uterine carcinosarcoma under multi-omics framework.
    Lu X; Zhang L; Zhao H; Chen C; Wang Y; Liu S; Lin X; Wang Y; Zhang Q; Lu T; Yan F
    Cancer Biol Ther; 2019; 20(2):227-235. PubMed ID: 30359167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
    Seidman JD; Chauhan S
    Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.
    Hensley ML
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):773-82. PubMed ID: 21752717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is minimally invasive surgery for clinical stage I uterine carcinosarcoma safe?
    Sinha R; Nizam A; Shan W; Shih KK; Frimer M; Sakaris A; Goldberg GL
    J Robot Surg; 2022 Aug; 16(4):943-949. PubMed ID: 34716874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine papillary serous cancer: a review of the literature.
    del Carmen MG; Birrer M; Schorge JO
    Gynecol Oncol; 2012 Dec; 127(3):651-61. PubMed ID: 23000148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: a case report.
    Kahraman K; Ortac F; Kankaya D; Aynaoglu G
    Taiwan J Obstet Gynecol; 2012 Mar; 51(1):89-92. PubMed ID: 22482976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic features of surgical stage I uterine carcinosarcoma.
    Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
    Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
    Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
    Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uterine carcinosarcoma].
    Serkies K; Jassem J
    Ginekol Pol; 2012 Aug; 83(8):609-12. PubMed ID: 23342885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Adjuvant Pelvic Radiotherapy on Distant Metastasis for Uterine Carcinosarcoma.
    Eng NL; Rana SR; Hall KL; Eng TY
    Am J Clin Oncol; 2021 Apr; 44(4):169-173. PubMed ID: 33481373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.